Statistics
Publications
33
Citations
3.7K
H-Index
26
Active since
2013
Dongling Zou is an author at Chongqing Cancer Hospital specializing in oncology, medicine, and molecular oncology.
Publications per year
2013–2024
33
33
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su, Lei Dong, Chenying Li et al. · Cell · 2017 · 1.2K citations · Full text
Medicine, Oncology, Pharmacology +10
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu, Qinglv Wei, Jing Jin et al. · Nucleic Acids Research · 2020 · 808 citations · Full text
Drug resistance in ovarian cancer: from mechanism to clinical trial
Ling Wang, Xin Wang, Xueping Zhu et al. · Molecular Cancer · 2024 · 238 citations · Full text
Medicine, Oncology, Pharmacology +17
Ning Li, Jianqing Zhu, Rutie Yin et al. · JAMA Oncology · 2023 · 159 citations · Full text
Medicine, Oncology, Pharmacotherapy +15
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
Dongling Zou, Lei Dong, Chenying Li et al. · Cancer Cell International · 2019 · 149 citations · Full text
1–5 of 33